Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD67 (SNORD67, previously LOC124900314) is a member of the C/D box snoRNA family, functioning in the modification and processing of ribosomal RNA within the nucleolus. It serves as a guide RNA for sequence-specific 2’-O-methylation of substrate RNAs, a critical step in ribosome biogenesis and general RNA metabolism. SNORD67 is not a protein and does not have traditional receptor, enzyme, or transporter activity. It is not considered a direct drug target and currently has no major disease linkage beyond its role as an essential RNA-processing molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD67 (SNORD67).